Donald G. Payan

2012

In 2012, Donald G. Payan earned a total compensation of $1.9M as Executive Vice President, President of Discovery and Research at Rigel Pharmaceuticals, a 64% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$256,808
Option Awards$1,102,840
Salary$540,648
Other$5,148
Total$1,905,444

Payan received $1.1M in option awards, accounting for 58% of the total pay in 2012.

Payan also received $256.8K in non-equity incentive plan, $540.6K in salary and $5.1K in other compensation.

Rankings

In 2012, Donald G. Payan's compensation ranked 3,731st out of 11,487 executives tracked by ExecPay. In other words, Payan earned more than 67.5% of executives.

ClassificationRankingPercentile
All
3,731
out of 11,487
68th
Division
Manufacturing
1,291
out of 4,253
70th
Major group
Chemicals And Allied Products
290
out of 1,198
76th
Industry group
Drugs
169
out of 920
82nd
Industry
Pharmaceutical Preparations
132
out of 700
81st
Source: SEC filing on March 30, 2015.

Payan's colleagues

We found four more compensation records of executives who worked with Donald G. Payan at Rigel Pharmaceuticals in 2012.

2012

James Gower

Rigel Pharmaceuticals

Chief Executive Officer

2012

Raul Rodriguez

Rigel Pharmaceuticals

Chief Executive Officer

2012

Elliott Grossbard

Rigel Pharmaceuticals

Chief Medical Officer

2012

Ryan Maynard

Rigel Pharmaceuticals

Chief Financial Officer

In-depth

You may also like